|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02389 BJ HEALTH
Nominal 
0.085 0.000 (0.000%) | 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Turnover | 76,587 | 4.474% | 149,945 | 140,346 | 166,484 | 203,776 |
| Cost of Sales | (56,192) | -1.288% | (114,265) | (101,872) | (119,972) | (156,785) |
| Gross Profit | 20,395 | 24.496% | 35,680 | 38,474 | 46,512 | 46,991 |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (1,250) | -55.373% | (5,751) | (15,163) | (10,109) | (7,030) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (7,991) | -21.910% | (30,434) | (23,020) | (43,498) | (17,885) | |
| Profit / (Loss) before Taxation | (30,312) | -49.766% | (119,421) | (68,778) | (102,696) | (46,619) | |
| Taxation | 1,000 | -63.807% | 3,846 | 7,057 | 3,891 | 6,385 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 76 | -93.493% | (643) | (161) | 1,109 | 824 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (29,236) | -48.173% | (116,218) | (61,882) | (97,696) | (39,410) | |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Finance Costs / (Income) | (3,444) | 433.127% | (4,617) | (15,231) | (12,990) | (18,412) |
| Depreciation & Amortisation | 10,554 | -3.801% | 21,721 | 24,211 | 26,007 | 34,181 |
| Directors' Emoluments | -- | -- | 8,083 | 6,491 | 5,707 | 6,820 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -0.480 | -48.387% | -1.920 | -1.010 | -1.610 | -0.650 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.006) | (0.007) | (0.005) | (0.003) |
| NBV per share ($) | 0.279 | -- | 0.283 | 0.311 | 0.336 | 0.377 |
| Remarks: | Real time quote last updated: 11/09/2025 17:29 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -29,236 |
| %Change | -48.173% |
| EPS / (LPS) | HKD -0.005 |
| NBV Per Share ($) | HKD 0.279 |